News
55m
Asianet Newsable on MSNHims & Hers Announces Plans To Expand Into Canada As Novo Nordisk’s Weight Loss Drug Patent ExpiresThe telehealth company stated that its entry to Canada will come as generic Semaglutide hits the market for the first time.
The Advertising Standards Authority said the rulings made it ‘crystal clear’ that prescription-only medicines could not be ...
2h
Independent.ie on MSNReal Health: What to expect when taking Ozempic?Are weight loss drugs the be-all and end-all? Are they for a little weight loss or only for a lot? And who should be taking them? John Kane, who used weight loss drug liraglutide better known as ...
Novo Nordisk's beaten-down valuation became too attractive to pass up, so I bought the stock earlier this year. Eli Lilly's ...
Learn how the benefits of GLP-1s may be outweighed by the risks.
Hims and Hers announced this morning that it will begin offering compounded semaglutide (generic Ozempic or Wegovy) for $199 ...
The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...
The recent approval of weight-loss drug Wegovy in New Zealand has been hyped as a breakthrough in the country’s fight against ...
ASA said the advert posted to her Instagram, which is still live, would 'likely' encourage people to 'request the ...
Hims & Hers announced plans to expand its weight loss program to Canada in 2026 in connection with the availability of generic semaglutide anywhere in the world.
The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug ...
The move follows a dramatic breakup in June between Hims & Hers and Danish drug maker Novo Nordisk, which makes the brand name weight loss drug Wegovy. Novo Nordisk accused the Hims & Hers of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results